Journal article · 2005 · Open access
Suppression of Virus Load by Highly Active Antiretroviral Therapy in Rhesus Macaques Infected with a Recombinant Simian Immunodeficiency Virus Containing Reverse Transcriptase from Human Immunodeficiency Virus Type 1
Journal of Virology, 79(12), 7349–7354 · Published 26 May 2005 · DOI 10.1128/jvi.79.12.7349-7354.2005
In brief
“Suppression of Virus Load by Highly Active Antiretroviral Therapy in Rhesus Macaques Infected with a Recombinant Simian Immunodeficiency Virus Containing Reverse Transcriptase from Human Immunodeficiency Virus Type 1” is a 2005 journal article by Thomas W. North and 6 co-authors, published in Journal of Virology. OpenAlex counts 74 citations as of 19 November 2026. It is open access: the full text is free to read at Europe PMC (PubMed Central).
- Citations
- 74
- Most cited in
- 2017 (5)
- Field-weighted impact
- 1.41
- References
- 42
- Authors
- 7
Abstract
We have modeled highly active antiretroviral therapy (HAART) for AIDS in rhesus macaques infected with a chimera (RT-SHIV) of simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type-1 (HIV-1). Seven RT-SHIV-infected macaques were treated with a combination of efavirenz (200 mg orally once daily), lamivudine (8 mg/kg subcutaneously once daily), and tenofovir (30 mg/kg subcutaneously once daily). Plasma viral RNA levels in all animals were reduced by more than 1,000-fold after 4 weeks and, in six of the seven animals, were reduced to undetectable levels after 10 weeks. Virus loads increased slightly between 12 and 16 weeks of treatment, associated with problems with the administration of efavirenz. After a change in the method of efavirenz administration, virus loads declined again and remained undetectable in the majority of animals for the duration of therapy. Treatment was stopped for three animals after 36 weeks of therapy, and virus loads increased rapidly. Posttreatment RT-SHIV isolates had no mutations associated with resistance to any of the three drugs. Efavirenz treatment was stopped, but lamivudine and tenofovir treatment for two other macaques was continued. The virus load in one of these two animals rebounded; virus from this animal was initially free of drug-resistance mutations but acquired the K65R mutation in reverse transcriptase at 11 weeks after efavirenz treatment was withdrawn. These results mimic HAART of HIV-1-infected humans. The RT-SHIV/rhesus macaque model should be useful for studies of tissue reservoirs and sites of residual replication that are not possible or practical with humans.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
North, T. W., Van Rompay, K. K. A., Higgins, J., Matthews, T. B., Wadford, D. A., Pedersen, N. C., & Schinazi, R. F. (2005). Suppression of Virus Load by Highly Active Antiretroviral Therapy in Rhesus Macaques Infected with a Recombinant Simian Immunodeficiency Virus Containing Reverse Transcriptase from Human Immunodeficiency Virus Type 1. Journal of Virology, 79(12), 7349–7354. https://doi.org/10.1128/jvi.79.12.7349-7354.2005
MLA 9
North, Thomas W., et al. “Suppression of Virus Load by Highly Active Antiretroviral Therapy in Rhesus Macaques Infected with a Recombinant Simian Immunodeficiency Virus Containing Reverse Transcriptase from Human Immunodeficiency Virus Type 1.” Journal of Virology, vol. 79, no. 12, 2005, pp. 7349–7354. https://doi.org/10.1128/jvi.79.12.7349-7354.2005.
Chicago
North, Thomas W., Koen K. A. Van Rompay, Joanne Higgins, Timothy B. Matthews, Debra A. Wadford, Niels C. Pedersen, and Raymond F. Schinazi. 2005. “Suppression of Virus Load by Highly Active Antiretroviral Therapy in Rhesus Macaques Infected with a Recombinant Simian Immunodeficiency Virus Containing Reverse Transcriptase from Human Immunodeficiency Virus Type 1.” Journal of Virology 79 (12): 7349–7354. https://doi.org/10.1128/jvi.79.12.7349-7354.2005.
Harvard
North, T. W. et al. (2005) ‘Suppression of Virus Load by Highly Active Antiretroviral Therapy in Rhesus Macaques Infected with a Recombinant Simian Immunodeficiency Virus Containing Reverse Transcriptase from Human Immunodeficiency Virus Type 1’, Journal of Virology, 79(12), pp. 7349–7354. doi:10.1128/jvi.79.12.7349-7354.2005.
IEEE
T. W. North et al., “Suppression of Virus Load by Highly Active Antiretroviral Therapy in Rhesus Macaques Infected with a Recombinant Simian Immunodeficiency Virus Containing Reverse Transcriptase from Human Immunodeficiency Virus Type 1,” Journal of Virology, vol. 79, no. 12, pp. 7349–7354, 2005, doi: 10.1128/jvi.79.12.7349-7354.2005.
BibTeX
@article{north2005suppression,
title = {{Suppression of Virus Load by Highly Active Antiretroviral Therapy in Rhesus Macaques Infected with a Recombinant Simian Immunodeficiency Virus Containing Reverse Transcriptase from Human Immunodeficiency Virus Type 1}},
author = {North, Thomas W. and Van Rompay, Koen K. A. and Higgins, Joanne and Matthews, Timothy B. and Wadford, Debra A. and Pedersen, Niels C. and Schinazi, Raymond F.},
journal = {Journal of Virology},
year = {2005},
volume = {79},
number = {12},
pages = {7349--7354},
doi = {10.1128/jvi.79.12.7349-7354.2005},
url = {https://doi.org/10.1128/jvi.79.12.7349-7354.2005}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2015 | 4 | |
| 2016 | 4 | |
| 2017 | 5 | |
| 2018 | 4 | |
| 2019 | 1 | |
| 2020 | 1 | |
| 2021 | 1 | |
| 2023 | 1 | |
| 2024 | 1 | |
| 2025 | 1 |
Its field-weighted citation impact is 1.41: it has been cited 1.41 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- highly active antiretroviral therapy
- HIV-1
- simian immunodeficiency virus
- rhesus monkeys
- viral suppression
- efavirenz
- lamivudine
- tenofovir
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
North, T. W., Van Rompay, K. K. A., Higgins, J., Matthews, T. B., Wadford, D. A., Pedersen, N. C., & Schinazi, R. F. (2005). Suppression of Virus Load by Highly Active Antiretroviral Therapy in Rhesus Macaques Infected with a Recombinant Simian Immunodeficiency Virus Containing Reverse Transcriptase from Human Immunodeficiency Virus Type 1. Journal of Virology, 79(12), 7349–7354. https://doi.org/10.1128/jvi.79.12.7349-7354.2005
How many times has this paper been cited?
74 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Europe PMC (PubMed Central): sign in and open the full text from this page.
Who wrote this paper?
Thomas W. North, Koen K. A. Van Rompay, Joanne Higgins, Timothy B. Matthews, Debra A. Wadford, Niels C. Pedersen, Raymond F. Schinazi.
What is the DOI of this paper?
10.1128/jvi.79.12.7349-7354.2005, permanently at https://doi.org/10.1128/jvi.79.12.7349-7354.2005. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.